Femasys FEMY
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
Key Insights
Femasys (FEMY) Core Market Data and Business Metrics
Latest Closing Price
$1.29Price-Earnings Ratio
-1.52Total Outstanding Shares
27.15 Million SharesDividend
No dividendSIC Description
Surgical & Medical Instruments & ApparatusPrimary Exchange
NASDAQHeadquarters
3950 Johns Creek Court, Suwanee, GA, 30024
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Short Interest
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
| Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
|---|---|---|---|
| 801,898 Shares | 1.43 | 3/14/2025 | 1,149,935 Shares |
| 691,878 Shares | 1 | 2/28/2025 | 658,919 Shares |
| 408,427 Shares | 1 | 2/14/2025 | 298,248 Shares |
| 223,782 Shares | 1 | 1/31/2025 | 144,684 Shares |
| 68,664 Shares | 3.46 | 1/15/2025 | 237,305 Shares |
| 140,714 Shares | 1.6 | 12/31/2024 | 225,833 Shares |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Financing Activities | $2.03 Million |
| Net Cash Flow From Operating Activities | $-19.44 Million |
| Net Cash Flow From Financing Activities, Continuing | $2.03 Million |
| Net Cash Flow From Operating Activities, Continuing | $-19.44 Million |
| Net Cash Flow From Investing Activities, Continuing | $-847,764 |
| Net Cash Flow, Continuing | $-18.26 Million |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Income Tax Expense/Benefit, Current | $9,602 |
| Benefits Costs and Expenses | $20.44 Million |
| Costs And Expenses | $20.44 Million |
| Income/Loss From Continuing Operations After Tax | $-18.82 Million |
| Net Income/Loss Available To Common Stockholders, Basic | $-18.82 Million |
| Net Income/Loss Attributable To Parent | $-18.82 Million |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss | $-18.82 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
| Other Comprehensive Income/Loss | $0 |
| Comprehensive Income/Loss Attributable To Parent | $-18.82 Million |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Assets | $12.45 Million |
| Equity | $2.30 Million |
| Accounts Payable | $1.42 Million |
| Other Non-current Assets | $2.83 Million |
| Noncurrent Liabilities | $1.56 Million |
| Liabilities | $10.14 Million |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||